A 52-year-old man with a 10-year history of Major Depressive Disorder has been on sertraline 100 mg daily for 8 weeks. He reports persistent depressed mood, fatigue, and anhedonia with minimal improvement. He denies suicidal ideation and tolerates the medication well with no adverse effects. What is the most appropriate next step in management?

Explanation

## Management of Treatment-Resistant Depression (TRD) — Step 1: Dose Optimization ### Clinical Context This patient has: - Chronic MDD (10-year history) - Inadequate response to sertraline 100 mg daily after 8 weeks - Good tolerability (no adverse effects) - No safety concerns (denies suicidal ideation) ### Definition of Inadequate Response **Key Point:** Inadequate response is defined as <50% reduction in depressive symptoms after 6–8 weeks at a therapeutic dose. At 8 weeks on sertraline 100 mg, this patient has not achieved remission and warrants intervention. ### Stepwise Approach to TRD ```mermaid flowchart TD A[Inadequate response to SSRI<br/>at 6-8 weeks]:::outcome --> B{Tolerating well?}:::decision B -->|Yes| C[Step 1: Increase to<br/>maximum tolerated dose]:::action B -->|No| D[Switch to different SSRI<br/>or different class]:::action C --> E{Response at<br/>higher dose?}:::decision E -->|Yes| F[Continue and monitor]:::action E -->|No| G[Step 2: Switch or<br/>Augment]:::action D --> G G --> H{Augmentation<br/>preferred?}:::decision H -->|Yes| I[Add aripiprazole,<br/>bupropion, or lithium]:::action H -->|No| J[Switch to different<br/>antidepressant class]:::action ``` ### Why Dose Increase Is First **High-Yield:** Before switching or augmenting, always optimize the current dose if: 1. The patient tolerates the medication well 2. The dose is below the maximum recommended range 3. Duration at current dose is adequate (6–8 weeks) **Mnemonic: DOSE-FIRST** — **D**ose optimization before switching, **O**ptimal duration (6–8 weeks), **S**afe and tolerated, **E**xplore higher range. **Clinical Pearl:** Sertraline's therapeutic range is 50–200 mg daily. At 100 mg, the patient is in the lower–middle range. Increasing to 150–200 mg may yield additional response in 20–30% of partial responders. ### Sertraline Dosing | Phase | Dose | Duration | |-------|------|----------| | Initial | 50 mg daily | 1 week | | Titration | 100 mg daily | 6–8 weeks (current) | | Optimization | 150–200 mg daily | 4 weeks | | Maximum | 200 mg daily | — | --- ## Comparison of Next-Step Options | Option | When to Use | Why Not Here | |--------|-------------|-------------| | **Increase dose** | Partial response, good tolerance, dose suboptimal | **CORRECT**: Sertraline 100 mg is below max; patient tolerates well | | Switch SSRI | Poor tolerance, no response at max dose | Premature; dose not optimized yet | | Augmentation | No response at max dose, or patient refuses switch | Premature; dose not maximized | | Switch to TCA | Augmentation failure, specific indication (e.g., pain) | Outdated; TCAs are 2nd/3rd line due to side effects | --- ## Key Guideline Points **Warning:** A common mistake is switching antidepressants too early. Always optimize dose first if tolerated. **Tip:** The timeline for reassessment after dose increase is 4 weeks (shorter than initial 6–8 weeks because the patient is already on the drug and has some baseline tolerance). [cite:Maudsley Guidelines 2023] [cite:Harrison 21e Ch 470] [cite:American Psychiatric Association Practice Guideline for MDD]